Exact Sciences Profit Margin

Exact Sciences (EXAS) currently reports a profit margin of -6.4% as of December 2025. That compares with -37.29% in the prior-year period — up 82.8% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Exact Sciences's profit margin history and peer comparisons.

Exact Sciences's profit margin increased from -37.29% to -6.4% — a 82.8% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exact Sciences's profit margin of -6.4% is lower than the Healthcare sector average of 13.76%. That is roughly 146.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Exact Sciences's current -6.4% should be judged against Healthcare norms (sector average: 13.76%) and against EXAS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Exact Sciences, and consider following EXAS for alerts when major investors trade the stock.